A citation-based method for searching scientific literature

Uriel Heresco-Levy, Daniel C Javitt, Richard Ebstein, Agnes Vass, Pesach Lichtenberg, Gali Bar, Sara Catinari, Marina Ermilov. Biol Psychiatry 2005
Times Cited: 264







List of co-cited articles
1501 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


D-serine added to antipsychotics for the treatment of schizophrenia.
G Tsai, P Yang, L C Chung, N Lange, J T Coyle. Biol Psychiatry 1998
502
75

High dose D-serine in the treatment of schizophrenia.
Joshua T Kantrowitz, Anil K Malhotra, Barbara Cornblatt, Gail Silipo, Andrea Balla, Raymond F Suckow, Cyril D'Souza, John Saksa, Scott W Woods, Daniel C Javitt. Schizophr Res 2010
158
50

Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.
Hsien-Yuan Lane, Yue-Cune Chang, Yi-Ching Liu, Chih-Chiang Chiu, Guochuan E Tsai. Arch Gen Psychiatry 2005
209
39

Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
Kenji Hashimoto, Takeshi Fukushima, Eiji Shimizu, Naoya Komatsu, Hiroyuki Watanabe, Naoyuki Shinoda, Michiko Nakazato, Chikara Kumakiri, Shin-ichi Okada, Hisanori Hasegawa,[...]. Arch Gen Psychiatry 2003
379
34

A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia.
Hsien-Yuan Lane, Ching-Hua Lin, Yu-Jhen Huang, Chun-Hui Liao, Yue-Cune Chang, Guochuan E Tsai. Int J Neuropsychopharmacol 2010
125
34

Recent advances in the phencyclidine model of schizophrenia.
D C Javitt, S R Zukin. Am J Psychiatry 1991
31

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
J H Krystal, L P Karper, J P Seibyl, G K Freeman, R Delaney, J D Bremner, G R Heninger, M B Bowers, D S Charney. Arch Gen Psychiatry 1994
31

A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia.
Mark Weiser, Uriel Heresco-Levy, Michael Davidson, Daniel C Javitt, Nomi Werbeloff, Ari A Gershon, Yehuda Abramovich, Daniela Amital, Adiel Doron, Shai Konas,[...]. J Clin Psychiatry 2012
66
43

D-alanine added to antipsychotics for the treatment of schizophrenia.
Guochuan E Tsai, Pinchen Yang, Yue-Cune Chang, Mian-Yoon Chong. Biol Psychiatry 2006
135
27


The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.
Robert W Buchanan, Daniel C Javitt, Stephen R Marder, Nina R Schooler, James M Gold, Robert P McMahon, Uriel Heresco-Levy, William T Carpenter. Am J Psychiatry 2007
293
26

Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor.
Hsien-Yuan Lane, Ching-Hua Lin, Michael F Green, Gerhard Hellemann, Chih-Chia Huang, Po-Wei Chen, Rene Tun, Yue-Cung Chang, Guochuan E Tsai. JAMA Psychiatry 2013
133
26

A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia.
Inna Bendikov, Carmit Nadri, Shirly Amar, Rogerio Panizzutti, Joari De Miranda, Herman Wolosker, Galila Agam. Schizophr Res 2007
236
25

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.
U Heresco-Levy, D C Javitt, M Ermilov, C Mordel, G Silipo, M Lichtenstein. Arch Gen Psychiatry 1999
355
25

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia.
Guochuan Tsai, Hsien-Yuan Lane, Pinchen Yang, Mian-Yoon Chong, Nicholas Lange. Biol Psychiatry 2004
259
25

D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor.
J P Mothet, A T Parent, H Wolosker, R O Brady, D J Linden, C D Ferris, M A Rogawski, S H Snyder. Proc Natl Acad Sci U S A 2000
846
24

Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients.
Kenji Hashimoto, Göran Engberg, Eiji Shimizu, Conny Nordin, Leif H Lindström, Masaomi Iyo. Prog Neuropsychopharmacol Biol Psychiatry 2005
196
24

High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia.
Uriel Heresco-Levy, Marina Ermilov, Pesah Lichtenberg, Gali Bar, Daniel C Javitt. Biol Psychiatry 2004
172
24

D-serine added to clozapine for the treatment of schizophrenia.
G E Tsai, P Yang, L C Chung, I C Tsai, C W Tsai, J T Coyle. Am J Psychiatry 1999
164
23

Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study.
Daniel Umbricht, Daniela Alberati, Meret Martin-Facklam, Edilio Borroni, Eriene A Youssef, Michael Ostland, Tanya L Wallace, Frédéric Knoflach, Ernest Dorflinger, Joseph G Wettstein,[...]. JAMA Psychiatry 2014
138
23

Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia.
U Heresco-Levy, D C Javitt, M Ermilov, C Mordel, A Horowitz, D Kelly. Br J Psychiatry 1996
198
20

Adjunctive high-dose glycine in the treatment of schizophrenia.
D C Javitt, G Silipo, A Cienfuegos, A M Shelley, N Bark, M Park, J P Lindenmayer, R Suckow, S R Zukin. Int J Neuropsychopharmacol 2001
122
20

Synthesis and biological evaluation of D-amino acid oxidase inhibitors.
Dana Ferraris, Bridget Duvall, Yao-Sen Ko, Ajit G Thomas, Camilo Rojas, Pavel Majer, Kenji Hashimoto, Takashi Tsukamoto. J Med Chem 2008
101
19

Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine.
Kenji Hashimoto, Yuko Fujita, Mao Horio, Shinsui Kunitachi, Masaomi Iyo, Dana Ferraris, Takashi Tsukamoto. Biol Psychiatry 2009
102
19

Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists.
Thomas Papouin, Laurent Ladépêche, Jérôme Ruel, Silvia Sacchi, Marilyne Labasque, Marwa Hanini, Laurent Groc, Loredano Pollegioni, Jean-Pierre Mothet, Stéphane H R Oliet. Cell 2012
441
19

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia.
Hsien-Yuan Lane, Chieh-Liang Huang, Po-Lun Wu, Yi-Ching Liu, Yue-Cune Chang, Pao-Yen Lin, Po-Wei Chen, Guochuan Tsai. Biol Psychiatry 2006
117
18

d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia.
Louise Verrall, Mary Walker, Nancy Rawlings, Isabel Benzel, James N C Kew, Paul J Harrison, Philip W J Burnet. Eur J Neurosci 2007
138
17

Plasma levels of D-serine in Brazilian individuals with schizophrenia.
Marilia A Calcia, Caroline Madeira, Flavio V Alheira, Thuany C S Silva, Filippe M Tannos, Charles Vargas-Lopes, Nelson Goldenstein, Marco Antonio Brasil, Sergio T Ferreira, Rogerio Panizzutti. Schizophr Res 2012
53
32

A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients.
Donald C Goff, Lawrence Herz, Thomas Posever, Vivian Shih, Guochuan Tsai, David C Henderson, Oliver Freudenreich, A Eden Evins, Iftah Yovel, Hui Zhang,[...]. Psychopharmacology (Berl) 2005
86
19

Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study.
Deepak C D'Souza, Rajiv Radhakrishnan, Edward Perry, Savita Bhakta, Nagendra M Singh, Richa Yadav, Danielle Abi-Saab, Brian Pittman, Santosh K Chaturvedi, Mahendra P Sharma,[...]. Neuropsychopharmacology 2013
50
34

Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels.
Kazuo Yamada, Tetsuo Ohnishi, Kenji Hashimoto, Hisako Ohba, Yoshimi Iwayama-Shigeno, Manabu Toyoshima, Akira Okuno, Hitomi Takao, Tomoko Toyota, Yoshio Minabe,[...]. Biol Psychiatry 2005
123
16

Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia.
Caroline Madeira, Maria Eliza Freitas, Charles Vargas-Lopes, Herman Wolosker, Rogério Panizzutti. Schizophr Res 2008
142
16

Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.
Ilya Chumakov, Marta Blumenfeld, Oxana Guerassimenko, Laurent Cavarec, Marta Palicio, Hadi Abderrahim, Lydie Bougueleret, Caroline Barry, Hiroaki Tanaka, Philippe La Rosa,[...]. Proc Natl Acad Sci U S A 2002
625
16

Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study.
Donald C Goff, Corinne Cather, Jennifer D Gottlieb, A Eden Evins, Jared Walsh, Lisa Raeke, Michael W Otto, David Schoenfeld, Michael F Green. Schizophr Res 2008
94
17

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.
D C Goff, G Tsai, J Levitt, E Amico, D Manoach, D A Schoenfeld, D L Hayden, R McCarley, J T Coyle. Arch Gen Psychiatry 1999
308
16

Glia-derived D-serine controls NMDA receptor activity and synaptic memory.
Aude Panatier, Dionysia T Theodosis, Jean-Pierre Mothet, Bastien Touquet, Loredano Pollegioni, Dominique A Poulain, Stéphane H R Oliet. Cell 2006
607
15

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.
Sandeep T Patil, Lu Zhang, Ferenc Martenyi, Stephen L Lowe, Kimberley A Jackson, Boris V Andreev, Alla S Avedisova, Leonid M Bardenstein, Issak Y Gurovich, Margarita A Morozova,[...]. Nat Med 2007
783
15

Sarcosine (N-methylglycine) treatment for acute schizophrenia: a randomized, double-blind study.
Hsien-Yuan Lane, Yi-Ching Liu, Chieh-Liang Huang, Yue-Cune Chang, Chun-Hui Liau, Cheng-Hwang Perng, Guochuan E Tsai. Biol Psychiatry 2008
115
15

Amelioration of negative symptoms in schizophrenia by glycine.
D C Javitt, I Zylberman, S R Zukin, U Heresco-Levy, J P Lindenmayer. Am J Psychiatry 1994
286
15



In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.
Tiziana Adage, Anne-Cécile Trillat, Anna Quattropani, Dominique Perrin, Laurent Cavarec, Jeffrey Shaw, Oxana Guerassimenko, Claudio Giachetti, Béatrice Gréco, Ilya Chumakov,[...]. Eur Neuropsychopharmacol 2008
100
14

Placebo-controlled trial of glycine added to clozapine in schizophrenia.
A E Evins, S M Fitzgerald, L Wine, R Rosselli, D C Goff. Am J Psychiatry 2000
126
14

D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial.
Joshua T Kantrowitz, Scott W Woods, Eva Petkova, Barbara Cornblatt, Cheryl M Corcoran, Huaihou Chen, Gail Silipo, Daniel C Javitt. Lancet Psychiatry 2015
91
15

The neurobiology of D-amino acid oxidase and its involvement in schizophrenia.
L Verrall, P W J Burnet, J F Betts, P J Harrison. Mol Psychiatry 2010
113
13

Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders.
Kenji Hashimoto, Berend Malchow, Peter Falkai, Andrea Schmitt. Eur Arch Psychiatry Clin Neurosci 2013
161
13

Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia.
Uriel Heresco-Levy, Marina Ermilov, Jonathan Shimoni, Baruch Shapira, Gail Silipo, Daniel C Javitt. Am J Psychiatry 2002
146
13

d-Cycloserine augmentation of cognitive remediation in schizophrenia.
Christopher K Cain, Margaret McCue, Iruma Bello, Timothy Creedon, Dei-In Tang, Eugene Laska, Donald C Goff. Schizophr Res 2014
52
25




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.